Comments on FINRA Rulemaking
Self-Regulatory Organizations; Notice of Filing and Immediate Effectiveness of a Proposed Rule Change to Amend FINRA Rule 2251 (Processing and Forwarding of Proxy and Other Issuer-Related Materials)
[Release No. 34-93769; File No. SR-FINRA-2021-032]
Submitted Comments |
|
| Dec. 14, 2021 | Paul T. Quinlan, General Counsel and Corporate Secretary, CymaBay Therapeutics, Inc. |